Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 775 of 6351
-
Cancer survivors may finally ditch heart pills: major trial underway
Disease control Recruiting nowCancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised. It is a side effect of cancer therapy which can occur as commonly as in 1 in 5 patients. When this occurs, heart failure medications are started to …
Phase 4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Engineered immune cells take on hard-to-treat prostate cancer
Disease control OngoingThis is one center, single-arm, open-label investigator initiated trial to assess the safety and efficacy of enhanced autologous PSMA chimeric antigen receptor T cells in the treatment for patients with refractory castration resistant prostate cancer, and the sample size is set t…
Early phase 1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo shows promise against tough esophageal cancer
Disease control OngoingDefinitive chemoradiotherapy (CRT) is the standard treatment option for unresectable locally advanced esophageal cancer. However, as high as more than 40% of patients with esophageal cancer experienced locoregional recurrence after definitive CRT. Immune checkpoint inhibitors tar…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a gentle brain zapping boost fading memory?
Symptom relief CompletedMild cognitive impairment (MCI) is a decline in memory and thinking that exceeds normal aging but does not substantially disrupt daily life, and it raises the risk of developing dementia. Effective treatments for its cognitive difficulties are few. This study tests whether trans…
Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Could a chemo drug shrink prostate tumors in men with BRCA mutations?
Disease control Recruiting nowThis phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the…
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Veterans with lung cancer may benefit from triple therapy approach
Disease control Recruiting nowThis study is a multicenter Phase II single arm trial to assess the safety and efficacy of chemotherapy and immunotherapy followed by radiotherapy in patients with unresectable Stage III NSCLC.
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Antidepressant may ease pain and PTSD after trauma
Symptom relief Recruiting nowWith this prospective double-blinded, placebo controlled clinical trial we hypothesize that immediate (post-injury) intervention with Fluoxetine will prevent/mitigate the development of negative psychiatric symptomology such as PTSD and depression for victims of bodily trauma. We…
Phase 4 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New MRI technique could end guesswork in brain tumor Follow-Up
Diagnosis OngoingBackground: Differentiating true progression (TP) from pseudoprogression (PsP) after glioma surgery remains a major clinical challenge because conventional magnetic resonance imaging (MRI) often cannot reliably distinguish these conditions. Objective: This prospective observatio…
Sponsor: Lanzhou University Second Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Targeted physiotherapy may speed pelvic recovery after delivery
Symptom relief CompletedThis study evaluated whether a 12-week exercise-based sensorimotor physiotherapy program could improve pelvic health and functional recovery in postpartum women. Participants were women aged 18-40 years who were between 6 weeks and 6 months after a singleton delivery. They were r…
Sponsor: Özge BAYKAN ÇOPUROĞLU • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a vacuum dressing prevent infections after leg amputation?
Disease control Recruiting nowPost-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance…
Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a new infusion drug tame lung inflammation and cut steroid use?
Disease control OngoingOpen-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new PET tracer spot tumors more clearly?
Diagnosis CancelledTo evaluate the safety of 18F-LNC1007 injection in the diagnosis of suspected tumor, initial stage, or recurrence monitoring; to explore the biological distribution of 18F-LNC1007 injection in patients; To compare the diagnostic efficacy of 18F-LNC1007 injection PET/CT versus 18F…
Sponsor: Jinling Hospital, China • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Can music lessons rewire Teens' social media habits?
Prevention CompletedThe primary goal of this interventional study is to explore whether 3 months of arts-based digital interventions can change the way in which teenagers (13-16 years of age) use social media and are affected by them. The main questions it aims to answer are: * Can we give teenager…
Sponsor: New York University • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
Could a common heartburn drug shield lung cancer patients from radiation side effects?
Symptom relief Recruiting nowThoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer (NSCLC).
Phase 2 • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a 6,000-Person study unlock personalized depression care for asians?
Knowledge-focused OngoingSHAKTI (from the Sanskrit word for "power") is a 5-year natural history, longitudinal, prospective study of a cohort of 6,000 participants that will help uncover the socio-demographic, lifestyle, clinical, psychological, and neurobiological factors that contribute to antidepressa…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New drug aims to stop liver scarring in Alpha-1 patients
Disease control Recruiting nowThe liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some people, the liver makes an abnormal version of the AAT protein, called Z-AAT. Making an abnormal version of the AAT protein can result in liver disease as Z-AAT b…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a simple breathing trick outperform the standard heart maneuver?
Disease control CompletedThe goal of this clinical trial is to compare two physical techniques for treating paroxysmal supraventricular tachycardia in adults. This condition causes a fast, regular heartbeat that starts and stops suddenly. Participants must be medically stable and have the condition confi…
Sponsor: Salih Karakoyun • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug aimed at stubborn high blood pressure passes final trial phase
Disease control CompletedThis is a Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety, tolerability and the effect of 2 mg Baxdrostat vs. placebo, administered QD orally, on the reduction of SBP, measured by average 24-hour ABPM in 212 partic…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New dissolving heart implant could ease migraines without metal side effects
Symptom relief Recruiting nowMigraine is one of the most common chronic neurological disorders, posing a significant global public health concern. Patent Foramen Ovale (PFO) is the most common congenital heart anomaly in adults. Mechanisms linking PFO to migraine include cortical spreading depression, vascul…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Radiation boosts immunotherapy in lung cancer trial
Disease control Recruiting nowThis is a randomized, controlled, open-label, multicenter phase II clinical trial comparing the efficacy and safety of low-dose radiation therapy and stereotactic body radiation therapy combined with PD-1 inhibitor (sintilimab) and standard platinum-based doublet chemotherapy ver…
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC